5 medtech stories we missed this week: Jan. 26, 2018

This article was originally published here
Share

[Image from unsplash.com]

From Attune Medical receiving FDA 510(k) clearance to Synapse Medical having CE Mark approval, here are 5 medtech stories we missed this week but thought were still worth mentioning.

1. Attune Medical gets FDA 510(k) clearance

Attune Medical announced in a Jan. 8 press release that it has received FDA 510(k) clearance for its EnsoETM model that administers tube feeds or medication while cooling or warming patients. The device manages a patient’s temperature through the esophagus while allowing for enteral fluid administration with the company’s ENFit connector.

2. Ally Bridge, LifeTech Scientific ink strategic Chinese partnership deal

Ally Bridge has entered a strategic partnership with LifeTech Scientific in China to help with commercialization and market entry in China, according to a Jan. 7 press release. Through the agreement, LifeTech has committed to invest in Ally Bridge funds and will continue to invest in other medtech companies. Additionally, ABG and LifeTech will set up a joint investment Fund to invest in other medical technologies globally.

3. ResMed launches Mobi portable oxygen concentrator

ResMed announced in a Jan. 8 press release that it has released its first portable oxygen concentrator, the Mobi. Mobi will be available to patients in the U.S. through home medical equipment providers and is currently in the process of getting clearance to launch the product in other countries.

4. Axonics wins Australian nod for sacral neuromod

Axonics has won Australian marketing approval for its Sacral Neuromodulation System, according to a Jan. 8 press release. The device is designed to treat overactive bladder, fecal incontinence and urinary retention. The approval allows the company to commercialize the device throughout Australia.

5. Synapse Biomedical gets CE Mark approval

Synapse Biomedical announced in a Jan. 8 press release that it has received CE Mark approval for its TransAeris System. The TransAeris system is a temporary diaphragm stimulator that is designed to be used in ICU patients who are on mechanical ventilation. The system gives patients life-sustaining respiration.

Here’s what we missed last week.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply